Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults
Public ClinicalTrials.gov record NCT00090077. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I, Multicenter, Randomized, Parallel, Double-Blinded Dose Ranging, Placebo-Controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of Four Oral Dosage Regimens of GW695634G Monotherapy Versus Placebo Over 10 Days in ART-Naive HIV-1 Infected Adults.
Study identification
- NCT ID
- NCT00090077
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Interventions
- GW695634 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2004
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Feb 26, 2006
Started 2004
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Clinical Trials Call Center | Phoenix | Arizona | 85006 | — |
| GSK Clinical Trials Call Center | Fountain Valley | California | 92708 | — |
| GSK Clinical Trials Call Center | San Francisco | California | 94115 | — |
| GSK Clinical Trials Call Center | West Hollywood | California | 90069 | — |
| GSK Clinical Trials Call Center | Washington D.C. | District of Columbia | 20007 | — |
| GSK Clinical Trials Call Center | Fort Lauderdale | Florida | 33308 | — |
| GSK Clinical Trials Call Center | Miami | Florida | 33136 | — |
| GSK Clinical Trials Call Center | Miami Beach | Florida | 33140 | — |
| GSK Clinical Trials Call Center | Orlando | Florida | 32804 | — |
| GSK Clinical Trials Call Center | Vero Beach | Florida | 32960 | — |
| GSK Clinical Trials Call Center | Atlanta | Georgia | 30308 | — |
| GSK Clinical Trials Call Center | Boston | Massachusetts | 02215 | — |
| GSK Clinical Trials Call Center | Las Vegas | Nevada | 89102 | — |
| GSK Clinical Trials Call Center | New York | New York | 10008 | — |
| GSK Clinical Trials Call Center | Charlotte | North Carolina | 28209 | — |
| GSK Clinical Trials Call Center | Oklahoma City | Oklahoma | 73104 | — |
| GSK Clinical Trials Call Center | Fort Worth | Texas | 76104 | — |
| GSK Clinical Trials Call Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00090077, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2006 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00090077 live on ClinicalTrials.gov.